Know Cancer

or
forgot password

Mindful Movement Program for Breast Cancer Survivors


N/A
50 Years
N/A
Not Enrolling
Female
Anxiety Disorder, Breast Cancer, Cancer Survivor, Cognitive/Functional Effects, Depression, Psychosocial Effects of Cancer and Its Treatment

Thank you

Trial Information

Mindful Movement Program for Breast Cancer Survivors


OBJECTIVES:

- To test the effects of the 12-week Mindful Movement Program on quality of life in older
female breast cancer survivors.

- To test the effects of this program on mindfulness outcomes in these participants.

- To compare mindfulness qualities in the experimental group with the control group.

- To determine the qualitative benefits of this program as described by these
participants.

OUTLINE: Participants are randomized to 1 of 2 intervention arms.

- Arm I (Mindful Movement Program [MMP]): Participants undergo a 2-hour MMP session once
weekly for 12 weeks. Participants are encouraged to practice intentional-mindful
movement at home 5 minutes daily during weeks 1-4, 10 minutes daily during weeks 5-8,
and 15 minutes daily during weeks 9-12. Mindful movement is a self-directed activity
incorporating mindfulness concepts and physical movement. Mindfulness consists of the
three core elements: intention (reasons for participating in a mindfulness
intervention), attention (observing experiences in the present moment), and attitude
(nonjudgmental openness and acceptance of experiences). Each MMP session includes
verbal sharing with a partner and the group and movement individually and with a
partner, while focusing on the elements of mindfulness. Music is incorporated into some
portion of each session.

- Arm II (control): Participants undergo no intervention. All participants complete
questionnaires for sociodemographic and individual characteristics, quality of life
(including psychological, social, spiritual, and physical well-being, anxiety and
depression, fear of recurrence, body image, and upper body symptoms), movement, and
mindfulness (including attention, self-compassion, and intention) at baseline and weeks
12 and 18.

PROJECTED ACCRUAL: A total of 75 participants (45 in the experimental group and 30 in the
control group) will be accrued for this study.

Inclusion Criteria


DISEASE CHARACTERISTICS:

- Breast cancer survivor

- At least 12 months since completion of treatment (chemotherapy, biotherapy
[e.g., trastuzumab], or radiotherapy)

- No evidence of metastatic disease

PATIENT CHARACTERISTICS:

- English speaking

- Not under acute psychological distress

- Not using an assistive device (cane, walker, or wheelchair)

- Able to participate in the Mindful Movement Program by a medical release from the
patient's physician

- Pregnancy allowed

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- Concurrent selective estrogen-receptor modulator permitted

- No other concurrent treatment

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care

Outcome Measure:

Effects of the Mindful Movement Program on psychological well-being, distress, fear of recurrence, physical well-being, upper-body symptom bother, social well-being, body image, and spiritual well-being at baseline and weeks 12 and 18

Outcome Time Frame:

6 months after study entry

Safety Issue:

No

Principal Investigator

Rebecca Crane-Okada, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Beckman Research Institute

Authority:

United States: Institutional Review Board

Study ID:

08061

NCT ID:

NCT00903474

Start Date:

August 2008

Completion Date:

Related Keywords:

  • Anxiety Disorder
  • Breast Cancer
  • Cancer Survivor
  • Cognitive/Functional Effects
  • Depression
  • Psychosocial Effects of Cancer and Its Treatment
  • anxiety disorder
  • depression
  • cognitive/functional effects
  • psychosocial effects of cancer and its treatment
  • cancer survivor
  • breast cancer
  • Anxiety Disorders
  • Breast Neoplasms
  • Depression
  • Depressive Disorder

Name

Location

City of Hope Comprehensive Cancer Center Duarte, California  91010